December 16, 2024 13:52 (IST)
Laurus Labs signs agreement with MPP for manufacturing Molnupiravir
Jan 22, 2022, at 03:12 am
Mumbai/UNI: Hyderabad-based Laurus Labs Limited on Friday said that it has signed an agreement with MPP (Medicine Patent Pool) for the manufacturing of the oral COVID-19 antiviral medication Molnupiravir.
Latest Headlines
Laurus Labs signs agreement with MPP for manufacturing Molnupiravir
Fri, Jan 21 2022